68 results
Page 2 of 4
424B5
43rshg77dkbj
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K/A
EX-99.2
fmjgq3k3fc9 38h
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.2
11x2j64bx7542f0lh
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
jecxp70td9 0kis58
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
gfwc myoyi
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-1.1
y6h3am1kyg873utha2vf
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.2
1lfmh3 jic7
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.1
pieu nx9kf
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
5kf51o
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
u0jza04b8ej5gw
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-4.1
8zr746poo2xobc7hw
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
4abeo x79qs
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
wxpc4airmwplq
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
0gc 4emd2c4u
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.2
eq7g eyh63wnd38p
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
30v8gbd797rhde8g
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm